There is a high level of medication usage among people with intellectual disability due to the presence of significant morbidity and co-morbidities. This review sought to explore medication management and administration in intellectual disability settings, identifying frameworks for practice, analysing whether collaborative practice led to better outcomes, identifying key processes associated with practice, locating tools to support practice and describing metrics for outcome measurement. A systematic review was conducted with analysis of 64 sources which remained following screening and appraisal. Limited evidence was identified with some insight into the processes underpinning medication management and administration. No assessment tools were found, but two potential outcome measures, adherence and errors, were noted. The paucity of guidelines and frameworks is concerning as this is a complex area of practice. There is a need for further practice development and research to be undertaken that takes note of the unique issues that can present in intellectual disability settings.
AbbottPAFosterJde Fatima MarinH, et al. (2014) Complexity and the science of implementation in health IT – knowledge gaps and future visions. International Journal of Medical Informatics83: e12–e22.
2.
AuberryKWillsKShaverC (2017) Improving medication practices for persons with intellectual and developmental disability: educating direct support staff using simulation, debriefing, and reflection. Journal of Intellectual Disabilities. DOI: 1744629517731231.
3.
AGREE Collaboration (2003) Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project. Quality and Safety in Health Care12: 18–23.
4.
BaxterHLoweKHoustonH, et al. (2006) Previously unidentified morbidity in patients with intellectual disability. British Journal of General Practice56: 93–98.
5.
BosnerSMBelfiorePJ (2001) Strategies and considerations for teaching an adolescent with Down syndrome and type I diabetes to self-administer insulin. Education and Training in Mental Retardation and Developmental Disabilities36: 94–102.
6.
BranfordDKniftonCJacksonS (1997) Drug administration in day centres for people with learning disabilities. British Journal of Nursing6: 746–750.
7.
BrasićJRFurmanJConteRM, et al. (2000) Assuring the quality of the utilization of psychoactive medication by people with mental retardation and developmental disabilities by assessing dosages. German Journal of Psychiatry3: 7–12.
8.
BrickeyM (1978) A behavioral procedure for teaching self-medication. Mental Retardation16: 29–32.
9.
BuckleyTS (2013) Moving toward best practice nursing guidelines in the care of intellectually disabled persons with epilepsy. Epilepsy Currents13: 23.
10.
BuelowJMShoreCP (2010) Management challenges in children with both epilepsy and intellectual disability. Clinical Nurse Specialist CNS24: 313–320.
11.
BulechekGMButcherHKMcCloskeyDochterman, et al. (2013) Nursing Interventions Classification (NIC). London: Elsevier.
12.
BurrowJRimmerJW (1997) Accuracy of medication records for patients with learning difficulties: an interface audit between the Phoenix NHS Trust and Avon Primary Care Audit Group. Journal of Clinical Effectiveness2: 3–5.
13.
CocksEThomsonAThoresenS, et al. (2016) Health status and use of medications by adults with intellectual disability in Western Australia. Journal of Intellectual & Developmental Disability41: 87–96.
14.
CrossleyRWithersP (2009) Antipsychotic medication and people with intellectual disabilities: their knowledge and experiences. Journal of Applied Research in Intellectual Disabilities22: 77–86.
15.
DamPEl-SouriMRossingC, et al. (2015) Quality and safety in medication use in residential facilities for the disabled: development of an educational programme. International Journal of Clinical Pharmacy37: 404.
16.
DavisS (2016) Asthma in intellectual disability: are we managing our patients appropriately?Breathe (Sheffield, England)12: 310–317.
17.
DavisSR (2014) Medication reviews for people with developmental disability – a call to action!Journal of Pharmacy Practice and Research44: 160–161.
18.
DavisSRDurvasulaSMerhiD, et al. (2015) The role of direct support professionals in asthma management. Journal of Intellectual & Developmental Disability40: 342–353.
19.
DavisSRDurvasulaSMerhiD, et al. (2016) Knowledge that people with intellectual disabilities have of their inhaled asthma medications: messages for pharmacists. International Journal of Clinical Pharmacy38: 135–143.
20.
DebSClarkeDUnwinG (2006) Using Medication to Manage Behaviour Problems Among Adults with a Learning Disability. Birmingham, UK: University of Birmingham.
21.
DeepakSObeEAttavarR (2012) Administration of emergency antiepileptics in staffed care homes for people with intellectual disabilities in High Wycombe: survey of staff training status. Advances in Mental Health and Intellectual Disabilities6: 41–46.
22.
Department of Health and Human Services (DHHS) (2017) Disability Services Medication Management Framework for Individuals and Disability Service Providers. Tasmania, Australia: Department of Health and Human Services.
23.
Department of Social and Health Services (DSHS) (2017) Residential Medication Management. Olympia, WA: Department of Social and Health Services.
24.
DharmapuriSBestDKindT, et al. (2015) Health literacy and medication adherence in adolescents. The Journal of Pediatrics166: 378–382.
DoanTNLennoxNGTaylor-GomezM, et al. (2013) Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study. Journal of Intellectual & Developmental Disability38: 177–181.
27.
DonnellyV (2013) How people with learning disabilities can help train professionals. Learning Disability Practice16: 24–26.
28.
DoyleCCroninP (2017) Difficulties in ‘giving medicines’ to children with severe and profound intellectual disabilities-mothers’ experiences. Archives of Disease in Childhood102: A16–A17.
29.
EllenorGLFriskPA (1977) Pharmacist impact on drug use in an institution for the mentally retarded. American Journal of Hospital Pharmacy34: 604–608.
30.
ElliottRAMarriottJL (2009) Standardised assessment of patients’ capacity to manage medications: a systematic review of published instruments. BMC Geriatrics9: 27.
31.
EpitropakisCDiPietroEA (2015) Medication compliance protocol for pediatric patients with severe intellectual and behavioral disabilities. Journal of Pediatric Nursing30: 329–332.
32.
EricksonSRSalgadoTMTanX (2016) Issues in the medication management process in people who have intellectual and developmental disabilities: a qualitative study of the caregivers’ perspective. Intellectual and Developmental Disabilities54: 412–426.
33.
FergusonLMurphyGH (2014) The effects of training on the ability of adults with an intellectual disability to give informed consent to medication. Journal of Intellectual Disability Research58: 864–873.
34.
GadowKDKaneKM (1983) Administration of medication by school personnel for trainable mentally retarded students. Journal of School Health53: 178–183.
35.
Government of Ireland (2015) Assisted Decision Making (Capacity) Act. Dublin, Ireland: The Stationery Office.
36.
HalderNDurairajSAslamY, et al. (2012) An audit on covert administration of medications to adults with learning disabilities. International Journal of Developmental Disabilities58: 129–136.
37.
Health Information and Quality Authority (HIQA) (2015) Medicines Management Guidance. Dublin, Ireland: HIQA.
38.
HeslopPFolkesLRodgersJ (2005) The knowledge people with learning disabilities and their carers have about psychotropic medication. Learning Disability Review10: 10–18.
39.
HigginsJGreenS (2011) Cochrane Handbook for Systematic Reviews of Interventions. London, UK: The Cochrane Collaboration.
40.
HomCLTouchettePNguyenV, et al. (2015) The relationship between living arrangement and adherence to antiepileptic medications among individuals with developmental disabilities. Journal of Intellectual Disability Research59: 48–54.
41.
HowsemanT (2013) Dysphagia in People with Learning Disabilities. Learning Disability Practice16: 14–22.
42.
HunekeNTGuptaRHalderN, et al. (2012) Difficult decisions: are intellectually disabled patients given enough information to consent to medical treatment?Journal of Intellectual Disability16: 265–274.
43.
HutchisonLCJonesSKWestDS, et al. (2006) Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study. The American Journal of Geriatric Pharmacotherapy4: 144–153.
44.
JoosEMehuysERemonJP, et al. (2016a) Analysis of drug use in institutionalized individuals with intellectual disability and tube feeding. Acta Clinica Belgica71: 76–80.
45.
JoosEMehuysEVan BocxlaerJ, et al. (2014) Medication management in Belgian residential care facilities for individuals with intellectual disability: an observational study. Journal of Policy and Practice in Intellectual Disabilities11: 27–33.
46.
JoosEMehuysEVan BocxlaerJ, et al. (2015) Drug administration via enteral feeding tubes in residential care facilities for individuals with intellectual disability: an observational study. Journal of Intellectual Disability Research59: 215–225.
47.
JoosEMehuysEVan BocxlaerJ, et al. (2016b) Knowledge of staff members of residential care facilities for individuals with intellectual disability on medication administration via enteral feeding tube. Journal of Intellectual Disability Research60: 1066–1072.
48.
JoosEVan TongelenIWijnantsK, et al. (2016c). Drug administration via enteral feeding tube in residential care facilities for individuals with intellectual disability: A focus group study on guideline implementation. Journal Of Intellectual Disabilities20: 329–340.
49.
KrahnGLHammondLTurnerA (2006) A cascade of disparities: health and health care access for people with intellectual disabilities. Mental Retardation and Developmental Disabilities Research Reviews12: 70–82.
50.
LoganathanMSinghSFranklinBD, et al. (2011) Interventions to optimise prescribing in care homes: systematic review. Age Ageing40: 150–162.
51.
MaidmentIDLelliottPPatonC (2006) Medication errors in mental healthcare: a systematic review. BMJ Quality and Safety15: 409–413.
52.
MoherDLiberatiATetzlaffJ, et al. (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med6: e1000097.
53.
National Federation of Voluntary Bodies (NFVB) (2009) Guidance on Policy and Guideline Development of Person-Centred Medication Management. Galway, Ireland: NFVB.
54.
National Institute of Health (2013) Assessing Cardiovascular Risk: Systematic Evidence Review from the Risk Assessment Work Group. Maryland: National Institute of Health.
55.
National Health Service (NHS) Trafford (2013) Guidance Regarding Covert Medication and Mental Capacity for Care Homes. Manchester: NHS Trafford.
56.
National Institute for Health and Care Excellence (NIHCE)2014. Managing Medicines in Care Homes. London, UK: NIHCE.
57.
O’DwyerMPeklarJMccallionP, et al. (2016) Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open6: e010505.
58.
PhamJCAswaniMSRosenM, et al. (2012) Reducing medical errors and adverse events. Annual Review of Medicine63: 447–463.
59.
RasaratnamRCrouchKReganA (2004) Attitude to medication of parents/primary carers of people with intellectual disability. Journal of Intellectual Disability Research48: 754–763.
60.
ShawNHodsonK (2016) Clinical pharmacist medication review of patients with learning disabilities: what types of interventions are made?International Journal of Pharmacy Practice24: 12–13.
61.
SohlerNLubetkinELevyJ, et al. (2009) Factors associated with obesity and coronary heart disease in people with intellectual disabilities. Social Work in Health Care48: 76–89.
62.
StupalskiKARussellGE (1999) Reported medication errors in community residences for individuals with mental retardation: a quality review. Mental Retardation37: 139–146.
63.
TanXMarshallVDBalkrishnanR, et al. (2015) Psychotropic medication adherence among community-based individuals with developmental disabilities and mental illness. Journal of Mental Health Research in Intellectual Disabilities8: 1–22.
64.
ThurtleV (2000) An audit of drug incidents in learning disability group homes. British Journal of Community Nursing5: 170–174.
65.
United Nations (2006) Convention on the rights of persons with disabilities. Geneva, Switzerland: United Nations.
66.
Van Den BemtPMLARobertzRDe JongAL, et al. (2007) Drug administration errors in an institution for individuals with intellectual disability: an observational study. Journal of Intellectual Disability Research51: 528–536.
67.
VenablesRStirlingHBatchelorH, et al. (2015) Problems with oral formulations prescribed to children: a focus group study of healthcare professionals. International Journal of Clinical Pharmacy37: 1057–1067.
68.
ZaalRJEbbersSBormsM, et al. (2016) Medication review using a Systematic Tool to Reduce Inappropriate Prescribing (STRIP) in adults with an intellectual disability: a pilot study. Research in Developmental Disabilities55: 132–142.
69.
ZijlstraHPVlaskampC (2005) Leisure provision for persons with profound intellectual and multiple disabilities: quality time or killing time?Journal of Intellectual Disability Research49: 434–448.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
